at://
/
app.bsky.feed.post
/
3mn65q3wpnk2m
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Last year our partners spearheaded a phase 2 clinical trial testing another engineered sialidase, Palleon’s E-602, in glomerulonephritis, an autoimmune disease of the kidney. Data readout later this year 🤞 palleonpharma.com/press-releas...
10d
palleonpharma.com
Palleon Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of E-602 (HLX79), a Potential First-In-Class Treatment for Active Glomerulonephritis – Palleon Pharmaceuticals
Carolyn Bertozzi
